Ole Havndrup

1.3k total citations
24 papers, 914 citations indexed

About

Ole Havndrup is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Epidemiology. According to data from OpenAlex, Ole Havndrup has authored 24 papers receiving a total of 914 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Cardiology and Cardiovascular Medicine, 8 papers in Molecular Biology and 4 papers in Epidemiology. Recurrent topics in Ole Havndrup's work include Cardiomyopathy and Myosin Studies (19 papers), Cardiovascular Function and Risk Factors (11 papers) and Cardiovascular Effects of Exercise (9 papers). Ole Havndrup is often cited by papers focused on Cardiomyopathy and Myosin Studies (19 papers), Cardiovascular Function and Risk Factors (11 papers) and Cardiovascular Effects of Exercise (9 papers). Ole Havndrup collaborates with scholars based in Denmark, United States and South Africa. Ole Havndrup's co-authors include Henning Bundgaard, Michael Christiansen, Paal Skytt Andersen, Morten K. Jensen, Lars Køber, Lars Allan Larsen, Carolyn Y. Ho, Anna Axelsson Raja, Jens Vuust and Paula L. Hedley and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and PLoS ONE.

In The Last Decade

Ole Havndrup

23 papers receiving 890 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ole Havndrup Denmark	15	786	291	179	66	55	24	914
Marta Rubino Italy	16	494 0.6×	210 0.7×	152 0.8×	92 1.4×	121 2.2×	65	727
Rachel Buchan United Kingdom	11	380 0.5×	412 1.4×	61 0.3×	57 0.9×	31 0.6×	27	715
Hideshi Niimura Japan	10	792 1.0×	426 1.5×	115 0.6×	41 0.6×	20 0.4×	20	911
Josef Veselka Czechia	22	1.3k 1.6×	153 0.5×	251 1.4×	126 1.9×	13 0.2×	109	1.4k
Pertti Jääskeläinen Finland	16	598 0.8×	232 0.8×	91 0.5×	26 0.4×	14 0.3×	27	664
A. Friedl Germany	7	440 0.6×	286 1.0×	30 0.2×	78 1.2×	34 0.6×	17	602
Francesca Brun Italy	15	950 1.2×	276 0.9×	41 0.2×	92 1.4×	27 0.5×	25	1.1k
Hans‐Jörg Weig Germany	12	312 0.4×	217 0.7×	50 0.3×	54 0.8×	18 0.3×	17	485
Jayal Shah United Kingdom	6	498 0.6×	154 0.5×	241 1.3×	86 1.3×	342 6.2×	9	831
Yanlin Xing China	8	244 0.3×	239 0.8×	30 0.2×	92 1.4×	15 0.3×	14	441

Countries citing papers authored by Ole Havndrup

Since Specialization

Citations

This map shows the geographic impact of Ole Havndrup's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ole Havndrup with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ole Havndrup more than expected).

Fields of papers citing papers by Ole Havndrup

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ole Havndrup. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ole Havndrup. The network helps show where Ole Havndrup may publish in the future.

Co-authorship network of co-authors of Ole Havndrup

This figure shows the co-authorship network connecting the top 25 collaborators of Ole Havndrup. A scholar is included among the top collaborators of Ole Havndrup based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ole Havndrup. Ole Havndrup is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Råmunddal, Truls, Emil Nielsen Holck, Ashkan Eftekhari, et al.. (2022). International randomized trial on the effect of revascularization or optimal medical therapy of chronic total coronary occlusions with myocardial ischemia - ISCHEMIA-CTO trial – rationale and design. American Heart Journal. 257. 41–50. 20 indexed citations

Raja, Anna Axelsson, Kasper Iversen, Niels Vejlstrup, et al.. (2015). THE EFFECT OF LOSARTAN ON DIASTOLIC FUNCTION, EXERCISE CAPACITY AND SYMPTOMS IN HYPERTROPHIC CARDIOMYOPATHY. Journal of the American College of Cardiology. 65(10). A857–A857. 2 indexed citations

Hagen, Christian M., Ole Havndrup, Paula L. Hedley, et al.. (2015). Private Mitochondrial DNA Variants in Danish Patients with Hypertrophic Cardiomyopathy. PLoS ONE. 10(4). e0124540–e0124540. 10 indexed citations

Jensen, Morten K., Ole Havndrup, Michael Christiansen, et al.. (2015). Echocardiographic evaluation of pre-diagnostic development in young relatives genetically predisposed to hypertrophic cardiomyopathy. International journal of cardiac imaging. 31(8). 1511–1518. 5 indexed citations

Raja, Anna Axelsson, Kasper Iversen, Niels Vejlstrup, et al.. (2014). Efficacy and safety of the angiotensin II receptor blocker losartan for hypertrophic cardiomyopathy: the INHERIT randomised, double-blind, placebo-controlled trial. The Lancet Diabetes & Endocrinology. 3(2). 123–131. 93 indexed citations

Raja, Anna Axelsson, Ole Havndrup, Henning Kelbæk, et al.. (2014). Atrioventricular conduction after alcohol septal ablation for obstructive hypertrophic cardiomyopathy. Journal of Cardiovascular Medicine. 15(3). 214–221. 10 indexed citations

Hagen, Christian M., Paula L. Hedley, Morten K. Jensen, et al.. (2013). Mitochondrial Haplogroups Modify the Risk of Developing Hypertrophic Cardiomyopathy in a Danish Population. PLoS ONE. 8(8). e71904–e71904. 32 indexed citations

Hagen, Christian M., Ole Havndrup, Paula L. Hedley, et al.. (2013). MT‐CYB mutations in hypertrophic cardiomyopathy. Molecular Genetics & Genomic Medicine. 1(3). 187–187.

Jensen, Morten K., Ole Havndrup, Michael Christiansen, et al.. (2012). Penetrance of Hypertrophic Cardiomyopathy in Children and Adolescents. Circulation. 127(1). 48–54. 84 indexed citations

10.

Lakdawala, Neal K., Jens Jakob Thune, Barry J. Maron, et al.. (2011). Electrocardiographic Features of Sarcomere Mutation Carriers With and Without Clinically Overt Hypertrophic Cardiomyopathy. The American Journal of Cardiology. 108(11). 1606–1613. 53 indexed citations

11.

Jensen, Morten K., Vibeke Marie Almaas, Peter Riis Hansen, et al.. (2011). Long-Term Outcome of Percutaneous Transluminal Septal Myocardial Ablation in Hypertrophic Obstructive Cardiomyopathy. Circulation Cardiovascular Interventions. 4(3). 256–265. 72 indexed citations

12.

Køber, Lars, et al.. (2011). [Another genetic cause of sudden cardiac death].. PubMed. 173(3). 190–3. 1 indexed citations

13.

Jensen, Morten K., Ole Havndrup, Christian Hassager, et al.. (2011). Survival and sudden cardiac death after septal ablation for hypertrophic obstructive cardiomyopathy. Scandinavian Cardiovascular Journal. 45(3). 153–160. 11 indexed citations

14.

Havndrup, Ole, Michael Christiansen, Morten K. Jensen, et al.. (2010). Fabry Disease Mimicking Hypertrophic Cardiomyopathy: Genetic Screening Needed for Establishing the Diagnosis in Women. European Journal of Heart Failure. 12(6). 535–540. 63 indexed citations

15.

Ho, Carolyn Y., Jens Jakob Thune, Ole Havndrup, et al.. (2009). Echocardiographic Strain Imaging to Assess Early and Late Consequences of Sarcomere Mutations in Hypertrophic Cardiomyopathy. Circulation Cardiovascular Genetics. 2(4). 314–321. 132 indexed citations

16.

Andersen, Paal Skytt, Ole Havndrup, Lotte Hougs, et al.. (2008). Diagnostic yield, interpretation, and clinical utility of mutation screening of sarcomere encoding genes in Danish hypertrophic cardiomyopathy patients and relatives. Human Mutation. 30(3). 363–370. 105 indexed citations

17.

Andersen, Paal Skytt, Ole Havndrup, Henning Bundgaard, et al.. (2004). Genetic and phenotypic characterization of mutations in myosin-binding protein C (MYBPC3) in 81 families with familial hypertrophic cardiomyopathy: total or partial haploinsufficiency. European Journal of Human Genetics. 12(8). 673–677. 58 indexed citations

18.

Hougs, Lotte, Ole Havndrup, Henning Bundgaard, et al.. (2004). One third of Danish hypertrophic cardiomyopathy patients have mutations in MYH7 rod region. European Journal of Human Genetics. 13(2). 161–165. 40 indexed citations

19.

Jørgensen, Erik, Henning Kelbæk, Steffen Helqvist, et al.. (2001). Predictors of coronary in-stent restenosis: importance of angiotensin-converting enzyme gene polymorphism and treatment with angiotensin-converting enzyme inhibitors. Journal of the American College of Cardiology. 38(5). 1434–1439. 34 indexed citations

20.

Bundgaard, Henning, Ole Havndrup, Paal Skytt Andersen, et al.. (1999). Familial Hypertrophic Cardiomyopathy Associated with a Novel Missense Mutation Affecting the ATP-binding Region of the Cardiac Beta-myosin Heavy Chain. Journal of Molecular and Cellular Cardiology. 31(4). 745–750. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact